The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Helix Biopharma Corp closed at $0.90.

Although unchanged over the last five days, shares are down 41.56% for the last year to date. This security has underperformed the S&P TSX by 52.04% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.13
Updated at previous session's close. Delayed by at least 15 minutes.
S&P TSX0.23%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedApr 30, 201704/30/2017Jan 31, 201701/31/2017Oct 31, 201610/31/2016Jul 31, 201607/31/2016
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense3333
Selling / general / administrative1111
Research & development2222
Depreciation / amortization--000
Interest expense (income), net operating--------
Unusual expense (income)00----
Other operating expenses, total--------
Operating income-3-3-3-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-3-3-3-3
Income after tax-3-3-3-3
Income tax, total--------
Net income-3-3-3-3
Total adjustments to net income--------
Net income before extra. items-3-3-3-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3-3-3-3
Inc. avail. to common incl. extra. items-3-3-3-3
Diluted net income-3-3-3-3
Dilution adjustment--------
Diluted weighted average shares92918988
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.03-0.04-0.03
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share-0.03-0.03-0.04-0.03